Biologically Relevant Murine Models of Chronic Pseudomonas aeruginosa Respiratory Infection

• Published in: Pathogens (Basel) Vol. 12; no. 8; p. 1053
• Main Authors: Rodgers, Aoife M., Lindsay, Jaime, Monahan, Avril, Dubois, Alice V., Faniyi, Aduragbemi A., Plant, Barry J., Mall, Marcus A., Ekkelenkamp, Miquel B., Elborn, Stuart, Ingram, Rebecca J.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 17.08.2023; MDPI
• Subjects: Animal models; Animals; Antimicrobial agents; Bacteria; Bacterial infections; Biofilms; Bronchopulmonary infection; Chronic infection; Clinical isolates; Cystic fibrosis; in vivo; Infections; Ketamine; Lungs; Microorganisms; Morbidity; Mortality; murine model; Opportunist infection; Pseudomonas aeruginosa; Respiration; respiratory; Respiratory tract infection; S. aureus; United Kingdom > UK; United States > US
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens12081053

Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic pathogen and the leading cause of infection in patients with cystic fibrosis (CF). The ability of P. aeruginosa to evade host responses and develop into chronic infection causes significant morbidity and mortality. Several mouse models have been developed to study chronic respiratory infections induced by P. aeruginosa, with the bead agar model being the most widely used. However, this model has several limitations, including the requirement for surgical procedures and high mortality rates. Herein, we describe novel and adapted biologically relevant models of chronic lung infection caused by P. aeruginosa. Three methods are described: a clinical isolate infection model, utilising isolates obtained from patients with CF; an incomplete antibiotic clearance model, leading to bacterial bounce-back; and the establishment of chronic infection; and an adapted water bottle chronic infection model. These models circumvent the requirement for a surgical procedure and, importantly, can be induced with clinical isolates of P. aeruginosa and in wild-type mice. We also demonstrate successful induction of chronic infection in the transgenic βENaC murine model of CF. We envisage that the models described will facilitate the investigations of host and microbial factors, and the efficacy of novel antimicrobials, during chronic P. aeruginosa respiratory infections.